Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Qualisure Diagnostics Inc. logo — Deploying AI-enabled molecular diagnostics globally through...

Qualisure Diagnostics Inc.

Deploying AI-enabled molecular diagnostics globally through decentralized testing and centralized interpretation.

Founded 2017 Canada Calgary, Canada 10 employees Seed Total: $850.00K Biotechnology, Health Care +1

General Information

Company Name Qualisure Diagnostics Inc.
Founded Year 2017
Location Canada Calgary, Canada
Employees 10
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Seed
Business Model B2B2C, Platform, SaaS
Revenue Model Service Fee, Usage Based, Subscription
Social

BounceWatch is an independent company data service, not affiliated with Qualisure Diagnostics Inc.. To contact Qualisure Diagnostics Inc., visit qualisuredx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Qualisure Diagnostics Inc. compare?

A PDF of Qualisure Diagnostics Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Qualisure Diagnostics Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Nov 06, 2026

Qualisure Diagnostics Inc. participated in a poster session at the American Thyroid Association, Inc. (ATA) meeting.

New Partnership Nov 04, 2026

Qualisure Diagnostics Inc. partnered with Amii to build a foundation model for bulk RNA sequencing data.

Qualisure Diagnostics Inc. a competitor of yours? Have our desk watch it

About Qualisure Diagnostics Inc.

Qualisure Diagnostics Inc. is at the forefront of precision oncology with its innovative approach to molecular diagnostics. Founded in 2017 and headquartered in Canada, this biotechnology startup is revolutionizing cancer treatment personalization through its proprietary Molecular deCodeR™ platform.

The company's slogan, "Deploying AI-enabled molecular diagnostics globally through decentralized testing and centralized interpretation," encapsulates its mission. By leveraging the synergy of molecular biology, artificial intelligence, and cloud-based solutions, Qualisure enhances diagnostic accuracy and accessibility worldwide without necessitating new infrastructure at each location.

Qualisure's flagship product, Thyroid GuidePx®, offers actionable insights for papillary thyroid cancer, streamlining treatment by identifying recurrence risks. The company collaborates with academic, clinical, and global partners, broadening its reach and impact. Having secured its latest investment as a Convertible Note in November 2022, Qualisure is well-positioned for further growth in the rapidly evolving life sciences sector.

Business keywords: Precision Oncology, Molecular Diagnostics, AI-Enabled Diagnostics, Decentralized Testing, Centralized Interpretation, Transcriptomic Diagnostics, Cloud-Based Deployment, Thyroid Cancer, Cancer Treatment Personalization, Biomarker Identification, Genomic Databases, Healthcare Scalability, Healthcare Cost Reduction, SaaS Solutions

Services & Products

Molecular risk testing for thyroid cancer
Development of diagnostic tests for cancer care
Personalized treatment guidance for oncologists

Target Customers

Oncologists Cancer Patients Physicians Healthcare Collaborators Investors

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
Genome Canada
Genome Canada
01 Mar 2026
Seed Undisclosed -
01 Sep 2022
Early VC $580.00K -
01 Mar 2021
Grant $100.00K 1
Alberta Innovates
Alberta Innovates
01 Nov 2020
Early VC $80.00K -
01 Dec 2019
Grant $10.00K -
01 Jan 2019
Early VC $80.00K -
01 Jun 2017
Spinout Undisclosed 1
University Ventures
University Ventures
01 Jan 2017

Qualisure Diagnostics Inc. Alternatives & Competitors

View All Alternatives
Qualisure Diagnostics Inc. vs
Veracyte, Inc.
Veracyte, Inc. United States

Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.

IPO
748 employees
Biotechnology, Health Care
Qualisure Diagnostics Inc. vs
OncoDNA
OncoDNA Belgium

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and g...

Series C
52 employees
Biotechnology, Health Care
Qualisure Diagnostics Inc. vs
TREOS THERAPEUTICS
TREOS THERAPEUTICS United Kingdom

Changing the paradigm of active cancer immunotherapy development

Convertible Note
17 employees
Biotechnology, Health Care
View all alternatives

FAQ About Qualisure Diagnostics Inc.

Deploying AI-enabled molecular diagnostics globally through decentralized testing and centralized interpretation.
Qualisure Diagnostics Inc. was founded in 2017.
Qualisure Diagnostics Inc. is headquartered in Calgary, Canada.
Qualisure Diagnostics Inc. operates in Biotechnology, Health Care and Life Sciences. Its work centres on Precision Oncology, Molecular Diagnostics, AI-Enabled Diagnostics and Decentralized Testing. Its customers include Oncologists, Cancer Patients and Physicians.
Qualisure Diagnostics Inc. has a B2B2C, Platform and SaaS business model. Its revenue comes from Service Fee, Usage Based and Subscription.
Qualisure Diagnostics Inc. has approximately 10 employees.
Qualisure Diagnostics Inc. has completed 8 funding rounds, raising a total of $850.00K. The latest funding stage is Seed.
Qualisure Diagnostics Inc. offers: Molecular risk testing for thyroid cancer, Development of diagnostic tests for cancer care, Personalized treatment guidance for oncologists.
Top alternatives and competitors to Qualisure Diagnostics Inc. include Veracyte, Inc., OncoDNA, TREOS THERAPEUTICS, Agendia, LCM Genect. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Qualisure Diagnostics Inc. and Veracyte, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Qualisure Diagnostics Inc., https://bouncewatch.com/company/qualisure-diagnostics-inc, updated 27 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout